Abstract:BACKGROUND: It has not been conclusively established that female pattern hair loss (FPHL) is either due to androgens or responsive to oral antiandrogen therapy.OBJECTIVES: To evaluate the efficacy of oral antiandrogen therapy in the management of women with FPHL using standardized photographic techniques (Canfield Scientific), and to identify clinical and histological parameters predictive of clinical response.METHODS: For this single-centre, before-after, open intervention study, 80 women aged between 12 and 79 years, with FPHL and biopsy-confirmed hair follicle miniaturization [terminal/vellus (T/V) hair ratio < or = 4 : 1] were photographed at baseline and again after receiving a minimum of 12 months of oral antiandrogen therapy. Forty women received spironolactone 200 mg daily and 40 women received cyproterone acetate, either 50 mg daily or 100 mg for 10 days per month if premenopausal. Women using topical minoxidil were excluded. Standardized photographs of the midfrontal and vertex scalp were taken with the head positioned in a stereotactic device. Images were evaluated by a panel of three clinicians experienced in the assessment of FPHL, blinded to patient details and treatment and using a three-point scale.RESULTS: As there was no significant difference in the results or the trend between spironolactone and cyproterone acetate the results were combined. Thirty-five (44%) women had hair regrowth, 35 (44%) had no clear change in hair density before and after treatment, and 10 (12%) experienced continuing hair loss during the treatment period. Ordinal logistic regression analysis to identify predictors of response revealed no influence of patient age, menopause status, serum ferritin, serum hormone levels, clinical stage (Ludwig) or histological parameters such as T/V ratio or fibrosis. The only significant predictor was midscalp clinical grade, with higher-scale values associated with a greater response (P = 0.013).CONCLUSION: Eighty-eight percent of women receiving oral antiandrogens could expect to see no progression of their FPHL or improvement. High midscalp clinical grade was the only predictor of response identified. A placebo-controlled study is required to compare this outcome to the natural history of FPHL.

Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know

Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study

Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review

Androgen-deprivation Therapy for Flutamide Resistant Prostate Cancer

Minimally invasive procedures for the management of female pattern hair loss

A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia

Androgenetic Alopecia: Therapy Update

Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies

Efficacy and safety of botulinum toxin A in the treatment of female pattern hair loss

Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women

Women’s hair loss: pathophysiological, diagnostic and therapeutic aspects

Treatment of female pattern hair loss with oral antiandrogens

Optimal use of topical minoxidil in management of female pattern hair loss in India: an expert opinion

Combination therapy in female pattern hair loss

Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness

Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature

The relative effect of monotherapy with 5-alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta-analysis study

Interventions for Female Pattern Hair Loss

Female Pattern Hair Loss: a clinical and pathophysiological review